Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter

MEA Reith, BE Blough, WC Hong, KT Jones… - Drug and alcohol …, 2015 - Elsevier
Background Treatment of stimulant-use disorders remains a formidable challenge, and the
dopamine transporter (DAT) remains a potential target for antagonist or agonist-like …

Bupropion and bupropion analogs as treatments for CNS disorders

FI Carroll, BE Blough, SW Mascarella… - Advances in …, 2014 - Elsevier
Bupropion, introduced as an antidepressant in the 1980s, is also effective as a smoking
cessation aid and is beneficial in the treatment of methamphetamine addiction, cocaine …

Dual dopamine/serotonin releasers as potential medications for stimulante and alcohol addictions

RB Rothman, BE Blough, MH Baumann - The AAPS journal, 2007 - Springer
We have advocated the idea of agonist therapy for treating cocaine addiction. This strategy
involves administration of stimulant-like medications (eg, monoamine releasers) to alleviate …

Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors

…, FI Carroll, JB Eaton, HA Navarro, BE Blough… - Molecular …, 2004 - ASPET
Bupropion is an atypical antidepressant that also has usefulness as a smoking-cessation aid.
Because hydroxybupropion, a major metabolite of bupropion, is believed to contribute to …

[HTML][HTML] N-substituted piperazines abused by humans mimic the molecular mechanism of 3, 4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy')

…, AG Budzynski, JS Partilla, BE Blough… - …, 2005 - nature.com
3, 4-Methylenedioxymethamphetamine (MDMA, or ‘Ecstasy’) is an illicit drug that stimulates
the release of serotonin (5-HT) and dopamine (DA) from neurons. Recent evidence reveals …

Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3, 4-methylenedioxypyrovalerone (MDPV)

JA Marusich, KR Antonazzo, JL Wiley, BE Blough… - …, 2014 - Elsevier
There has been a dramatic rise in the abuse of synthetic cathinones known as “bath salts,”
including 3,4-methylenedioxypyrovalerone (MDPV), an analog linked to many adverse events…

Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs

…, MH Baumann, RB Rothman, BE Blough… - … of Pharmacology and …, 2005 - ASPET
It has been reported that among drugs with mixed actions on central nervous system
monoamine systems, increased serotonergic activity is associated with decreased potency as a …

Interaction of amphetamines and related compounds at the vesicular monoamine transporter

JS Partilla, AG Dempsey, AS Nagpal, BE Blough… - … of Pharmacology and …, 2006 - ASPET
Amphetamine-type agents interact with the vesicular monoamine transporter type 2 (VMAT
2 ), promoting the release of intravesicular neurotransmitter and an increase in cytoplasmic …

Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and …

…, B David, KH Muchhala, BE Blough… - Journal of …, 2017 - journals.sagepub.com
Rationale: TRV130 (oliceridine; N-[(3-methoxythiophen-2-yl)methyl]-2-[(9R)-9-pyridin-2-yl-6-oxaspiro[4.5]decan-9-yl]ethanamine)
is a novel mu opioid receptor (MOR) agonist that …

Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction

FI Carroll, BE Blough, P Abraham… - Journal of medicinal …, 2009 - ACS Publications
A series of bupropion (1a) analogues (1b−1ff) were synthesized, and their in vitro and in vivo
pharmacological properties evaluated with the goal of developing a 1a analogue that had …